Cargando…

HBV infection potentiates resistance to S-phase arrest-inducing chemotherapeutics by inhibiting CHK2 pathway in diffuse large B-cell lymphoma

A considerable number of diffuse large B-cell lymphoma (DLBCL) patients are infected with hepatitis B virus (HBV), which is correlated with their poor outcomes. However, the role of HBV infection in DLBCL treatment failure remains poorly understood. Here, our data demonstrated that HBV infection was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xinying, Guo, Xudong, Xing, Libo, Yue, Wenqin, Yin, Haisen, He, Miaoxia, Wang, Jianmin, Yang, Jianmin, Chen, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833392/ https://www.ncbi.nlm.nih.gov/pubmed/29352124 http://dx.doi.org/10.1038/s41419-017-0097-1

Ejemplares similares

Artemether suppresses cell proliferation and induces apoptosis in diffuse large B cell lymphoma cells
por: Zhao, Xinying, et al.
Publicado: (2017)

Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma
por: Su, Yinghan, et al.
Publicado: (2016)

Functional and molecular interactions between ERK and CHK2 in diffuse large B-cell lymphoma
por: Dai, Bojie, et al.
Publicado: (2011)

SAMHD1 Mutations and Expression in Mantle Cell Lymphoma Patients
por: Wang, Tao, et al.
Publicado: (2021)

B2M mutation paves the way for immune tolerance in pathogenesis of Epstein-Barr virus positive diffuse large B-cell lymphomas
por: He, Miaoxia, et al.
Publicado: (2022)

Pterostilbene induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma cells
por: Kong, Yuanyuan, et al.
Publicado: (2016)

Aggregative Perivascular Tumor Cell Growth Pattern of Primary Central Nervous System Lymphomas Is Associated with Hypoxia-Related Endoplasmic Reticulum Stress
por: He, Miaoxia, et al.
Publicado: (2021)

Keeping RelApse in Chk: molecular mechanisms of Chk1 inhibitor resistance in lymphoma
por: Black, Elizabeth M., et al.
Publicado: (2022)

Activation of mammalian Chk1 during DNA replication arrest: a role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing
por: Feijoo, Carmen, et al.
Publicado: (2001)

Dominant mutations in CHK1 cause pronuclear fusion failure and zygote arrest that can be rescued by CHK1 inhibitor
por: Zhang, Honghui, et al.
Publicado: (2021)

Clinical Significance of “Double-hit” and “Double-protein” expression in Primary Gastric B-cell Lymphomas
por: He, Miaoxia, et al.
Publicado: (2016)

Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells
por: Cui, Qingbin, et al.
Publicado: (2019)

Chk1, Chk2, is the amplifier on?
por: Dove, Alan W.
Publicado: (2001)

Unravelling the hidden heterogeneities of diffuse large B-cell lymphoma based on coupled two-way clustering
por: Zhang, Wei, et al.
Publicado: (2007)

Diffuse large B-cell lymphoma presenting in the leukemic phase
por: Pires, Patricia Puccetti, et al.
Publicado: (2016)

IDO, TDO, and AHR overexpression is associated with poor outcome in diffuse large B-cell lymphoma patients in the rituximab era
por: Chen, Xiangli, et al.
Publicado: (2020)

Editorial: HBV and lymphoma
por: Gentile, Giuseppe, et al.
Publicado: (2023)

A model to predict the prognosis of diffuse large B-cell lymphoma based on ultrasound images
por: Lu, Wenjuan, et al.
Publicado: (2023)

Omacetaxine mepesuccinate induces apoptosis and cell cycle arrest, promotes cell differentiation, and reduces telomerase activity in diffuse large B-cell lymphoma cells
por: ZHANG, LINA, et al.
Publicado: (2016)

Functional interaction between BLM helicase and 53BP1 in a Chk1-mediated pathway during S-phase arrest
por: Sengupta, Sagar, et al.
Publicado: (2004)

Leukemic Phase of CD5+ Diffuse Large B-Cell Lymphoma
por: Hsiao, Hui-Hua, et al.
Publicado: (2018)

The nucleolus stress response is coupled to an ATR-Chk1–mediated G2 arrest
por: Ma, Hanhui, et al.
Publicado: (2013)

A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma
por: Shi, Yuankai, et al.
Publicado: (2020)

TUC338 Promotes Diffuse Large B Cell Lymphoma Growth via Regulating EGFR/PI3K/AKT Signaling Pathway
por: Li, Yan, et al.
Publicado: (2021)

Risk of HBV reactivation in relapsed or refractory diffuse large B-cell lymphoma patients receiving Bruton tyrosine kinase inhibitors therapy
por: Ni, Ying, et al.
Publicado: (2022)

Mus81 knockdown improves chemosensitivity of hepatocellular carcinoma cells by inducing S‐phase arrest and promoting apoptosis through CHK1 pathway
por: Wu, Fan, et al.
Publicado: (2015)

Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells
por: Herůdková, Jarmila, et al.
Publicado: (2017)

Correction for The nucleolus stress response is coupled to an ATR-Chk1–mediated G2 arrest
Publicado: (2013)

MicroRNA-155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell Lymphoma
por: Zhu, Fu-qiang, et al.
Publicado: (2016)

Extremely Low-Frequency Electromagnetic Fields Cause G1 Phase Arrest through the Activation of the ATM-Chk2-p21 Pathway
por: Huang, Chao-Ying, et al.
Publicado: (2014)

Mangrove dolabrane‐type of diterpenes tagalsins suppresses tumor growth via ROS‐mediated apoptosis and ATM/ATR–Chk1/Chk2‐regulated cell cycle arrest
por: Neumann, Jennifer, et al.
Publicado: (2015)

Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer
por: Dufau, Isabelle, et al.
Publicado: (2012)

Regulation of Chk1
por: Tapia-Alveal, Claudia, et al.
Publicado: (2009)

Diffuse Large B-Cell Lymphoma Relapsing in Leukaemic Phase Presenting as Acute Leukaemia
por: Balasubramanian, Priyavadhana, et al.
Publicado: (2019)

Clinical Analysis of the HBV Infection Status of 135 Patients with Diffuse Large B Cell Lymphoma Treated with R-CHOP or CHOP/CHOP-Like Chemotherapy
por: Guo, Wei, et al.
Publicado: (2015)

High expression of neuroguidin increases the sensitivity of acute myeloid leukemia cells to chemotherapeutic drugs
por: Chen, Kejun, et al.
Publicado: (2015)

Identification and Validation of a Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma
por: Yan, Jiaqin, et al.
Publicado: (2022)

Cytokines and Chemokines in HBV Infection
por: Zhong, Shihong, et al.
Publicado: (2021)

In silico and in vivo analysis of TIPE1 expression in diffuse large B cell lymphoma
por: Shen, Pei, et al.
Publicado: (2022)

Sodium fluoride causes hepatocellular S-phase arrest by activating ATM-p53-p21 and ATR-Chk1-Cdc25A pathways in mice
por: Liu, Huan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0cknckc1bnbr3avbg2ipp7r829